CRISPR's 2026 CASGEVY And Pipeline Expansion Plans Could Be A Game Changer For CRSP [Yahoo! Finance]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Yahoo! Finance
The company highlighted a data- and milestone-rich year ahead, including new clinical trial initiations for CTX460 in alpha-1 antitrypsin deficiency and CTX340 in refractory hypertension, underscoring the breadth of its pipeline beyond its first commercial product. We'll now examine how this focus on expanding CASGEVY commercialization and advancing new clinical programs could influence CRISPR Therapeutics' investment narrative. Find companies with promising cash flow potential yet trading below their fair value To own CRISPR Therapeutics, you have to believe that CASGEVY can anchor a broader, durable gene-editing franchise while the company manages years of losses and heavy R&D spend. The J.P. Morgan presentation reinforces that story rather than changing it, by sharpening attention on near term catalysts around CASGEVY's global rollout and a crowded 2026 data calendar across CTX310, CTX611 and zugo cel, plus first-in-human plans for CTX460 and CTX340. That keeps clinical and
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- Crispr Therapeutics: Patience And Opportunity Through Volatility [Seeking Alpha]Seeking Alpha
- Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics (CRSP) Is Considered a Good Investment by Brokers: Is That True? [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 MilestonesGlobeNewswire
- Is CRISPR Therapeutics (CRSP) Attractive After Recent Gene Editing Progress And Mixed Returns? [Yahoo! Finance]Yahoo! Finance
CRSP
Earnings
- 11/10/25 - Beat
CRSP
Sec Filings
- 1/12/26 - Form 8-K
- 1/8/26 - Form 4
- 1/6/26 - Form 144
- CRSP's page on the SEC website